Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-07-08 00:00:00 ET · period of report 2024-07-05 · accession 0001415889-24-019332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-08 | 2024-07-05 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.79 | +1,792 | 47.6K | +4% | +$5,000 |
| D | 2024-07-08 | 2024-07-05 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $6.03 | -1,173 | 46.5K | -2% | -$7,073 |
| D | 2024-07-08 | 2024-07-05 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.79 | -1,792 | 179.8K | -1.0% | -$5,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-07-05 | M | A | 1,792 | $2.79 | 47,630 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023. |
| 2 | Common | Common Shares | 2024-07-05 | S | D | 1,173 | $6.03 | 46,457 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 3 | Derivative | Common Shares | 2024-07-05 | M | D | 1,792 | $2.79 | 179,802 | D | $2.79 · 2014-08-04 to 2024-08-04 | 1,792 Options | (F3) Represents options exercised pursuant to a 10b5-1 program adopted August 17, 2023. |